USE OF PRODUCTS IN CAPITAL PUNISHMENT
Hikma aims to improve lives by providing patients with access to high quality, affordable medicines. Our medicines are used thousands of times a day around the world to treat illness and save lives.
We object in the strongest possible terms to the use of any of our Products for the purpose of Capital Punishment. Not only is it contrary to the intended label use(s) for the Products, but it is also inconsistent with our values and mission of improving lives by providing quality, affordable healthcare to patients.
While none of our Products should ever be used for the purpose of Capital Punishment, set forth below, we have identified certain product-families that carry heightened risk of misuse for lethal injection protocols. Accordingly, to prevent these Products from these product-families being used for the purpose of Capital Punishment, we will not accept orders for Products from these product-families directly from any Departments of Correction or correctional facilities in the United States, unless accompanied by an original, raised seal copy of an affidavit signed by the state Attorney General (or Governor), certifying under penalty of perjury that the Product(s) will not be used for Capital Punishment. Further, we will only sell these Products to pre-selected commercial customers who agree that they will not then sell or provide them to: (i) Departments of Corrections; (ii) correctional facilities; (iii) secondary distributors; or (iv) retail pharmacies.
Hikma vigorously monitors the distribution of these Products and support industry serialisation efforts that will help enhance these controls while continuing to promote our values and mission.
Transparency is one of our core values, and as such Hikma also objects to attempts by any entity, person or state to obscure or hide the source of Products for lethal injection. It is imperative that we are not impeded from protecting patient health and the integrity of our Products and our supply chain.
PRODUCT-FAMILY NAME
- ATIVAN INJECTION
- CISATRACURIUM BESYLATE INJECTION
- DIAZEPAM INJECTION
- ETOMIDATE INJECTION
- FENTANYL CITRATE INJECTION
- HYDROMORPHONE HCL INJECTION
- KETAMINE HCL INJECTION
- LORAZEPAM INJECTION
- MIDAZOLAM HCL INJECTION
- MIDAZOLAM SODIUM CHLORIDE INJECTION
- PENTOBARBITAL SODIUM INJECTION
- PHENOBARBITAL SODIUM INJECTION
- PROPOFOL INJECTION EMULSION
- REMIFENTANIL HCL INJECTION
- ROCURONIUM BROMIDE INJECTION
- SUCCINYLCHOLINE CHLORIDE INJECTION
- VECURONIUM BROMIDE INJECTION
Last updated: 8 December 2023